Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Other Non-Current Assets (2012 - 2026)

Rezolute (RZLT) posted Other Non-Current Assets of $2.4 million for Q1 2026, up 1.71% sequentially from $2.4 million in Q4 2025, and down 16.48% YoY from $2.9 million in Q1 2025.

Analysis

Rezolute (RZLT) Other Non-Current Assets (2012 - 2026) Analysis & Trends

Rezolute has reported Other Non-Current Assets for 14 years, with the latest figure at $2.4 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 16.48% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 16.48% YoY) and the FY2025 annual result came in at $2.9 million, up 59.14% from the prior year.
  • Other Non-Current Assets grew to $2.4 million in Q1 2026 per RZLT's latest filing, from $2.4 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $5.0 million in Q1 2022 and troughed at $148000.0 in Q2 2022.
  • A 5-year average of $1.7 million and a median of $1.8 million in 2024 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 41566.67% in 2022, down 97.04% in 2022.
  • Over 5 years, Other Non-Current Assets stood at $148000.0 in 2022, then soared by 213.51% to $464000.0 in 2023, then surged by 510.34% to $2.8 million in 2024, then retreated by 15.18% to $2.4 million in 2025, then rose by 1.71% to $2.4 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.4 million, $2.4 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Rezolute 477.02 Mn 477.02 Mn - 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.44 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 2.68 Mn
Jun 30, 2025 2.93 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 1.84 Mn
Jun 30, 2024 1.84 Mn
Mar 31, 2024 1.84 Mn
Dec 31, 2023 464,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 148,000.00
Mar 31, 2023 148,000.00
Dec 31, 2022 148,000.00
Sep 30, 2022 148,000.00
Jun 30, 2022 148,000.00
Mar 31, 2022 5.00 Mn
Dec 31, 2021 5.00 Mn
Sep 30, 2021 72,000.00
Jun 30, 2021 191,000.00